The Oncology Pharmacist® features articles written by and for oncology pharmacists and specifically addresses the issues pharmacists and their colleagues face every day in clinical practice.
At the Association of Community Cancer Centers 49th Annual Meeting & Cancer Business Summit, Andre Harvin, PharmD, MS, MBA, Executive Director of Pharmacy, Oncology Services, Cone Health Cancer Center, Greensboro, NC, presented a keynote lecture titled, “Robots, Biologics, and Advocates: Lessons from the Pharmacy.”
Study Shows Health Insurance Status Mediates Racial and Ethnic Inequities in Advanced-Stage Cervical CancerHealth insurance coverage mediated racial and ethnic inequities among patients with advanced-stage cervical cancer, according to findings from a recent retrospective, cross-sectional, population-based study.
Biomarker testing is a necessary tool in the advancing world of precision cancer treatment. According to a new survey released by CancerCare, a leading national cancer support organization, biomarker testing helped physicians tailor therapy for nearly all the respondent patients (93%) whose cancers were tested over the past 3 years.
Top Trending Articles
In the Literature
Practical Issues for Pharmacists
It is estimated that approximately 64,050 individuals (33,130 men and 30,920 women) in the United States will be diagnosed with pancreatic cancer in 2023, and approximately 50,550 individuals (26,620 men and 23,930 women) will die from the disease. How much do you know about pancreatic cancer?
According to recent results published in Clinical Cancer Research, patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not.